Study Comparing the Effects of Latanoprostene Bunod and Timolol on Retinal Blood Vessel Density and Visual Acuity

Conditions:   OAG – Open-Angle Glaucoma;   OHT – Ocular Hypertension
Interventions:   Drug: Latanoprostene bunod 0.024% QD;   Drug: Timolol maleate 0.5% BID
Sponsors:   University of California, San Diego;   Bausch & Lomb Incorporated
Recruiting
ClinicalTrials.gov: Ophthalmology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days